News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA) to Buy Dyax Corp. (DYAX)'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals



10/13/2009 6:50:52 AM

Bookmark and Share

Reuters -- French drugmaker Sanofi-Aventis agreed to acquire Fovea Pharmaceuticals, which is jointly developing a drug with Dyax Corp to treat an eye indication.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES